RxDoctor Payments Data

Carlos Bechara, MD

Vascular Surgery · Maywood, ILNPI 1639357585

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $129,690 of the $199,097 with a category attached, or 65.1%. 25 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 45.5% of the total. Reporting peaked in 2019 at $60,327 and has fallen 86.1% since, to $8,365 in 2025. Among vascular surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$199,097in general payments, 2019–2025

Across 335 payments — averaging $594.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$91K
  • Cook Incorporated$75K
  • Penumbra, Inc.$17K
  • Cook Medical LLC$11K
  • Medtronic$1K
  • Wilson Cook Medical Incorporated$1K
  • plus $2K from 19 others

What the payments were for

  • Consulting fees$36,56818%
  • Speaking & faculty fees$129,69065%
  • Grants$2,9011%
  • Travel & lodging$13,6407%
  • Food & beverage$16,2418%
  • Education$570%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$199,097 in reported general payments places this provider in the 95th percentile of 170 vascular surgery providers in Illinois.

See all vascular surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$146,087
Medicare patients
506
Services billed
896

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate35$417

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Maywood

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →